BDTX
Black Diamond Therapeutics Inc
NASDAQ: BDTX · HEALTHCARE · BIOTECHNOLOGY
$2.65
+3.11% today
Updated 2026-04-30
Market cap
$170.15M
P/E ratio
7.62
P/S ratio
2.43x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$1 – $5
Volume
0.7M
Black Diamond Therapeutics Inc (BDTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.35M | $-8.45M | $-24.67M | $-52.15M | $-100.15M | $-85.08M | $-66.72M | $-62.30M | $29.61M |
| Capital expenditures | $77000.00 | $76000.00 | $21000.00 | $142000.00 | $2.71M | $192000.00 | $33000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $5000.00 | $64000.00 | $3.64M | $7.76M | $14.04M | $12.20M | $9.60M | $10.63M | $6.63M |
| Free cash flow | $-2.43M | $-8.53M | $-24.70M | $-52.29M | $-102.86M | $-85.27M | $-66.75M | $-62.30M | $29.61M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-118.89M | $31.19M | $-31.54M | — | — | — |